美股市場個股詳情
CPRX Catalyst Pharmaceuticals
- 16.490
- +0.090+0.55%
收盤價 05/17 16:00 (美東)
- 16.350
- -0.140-0.85%
盤後 19:08 (美東)
19.48億總市值29.45市盈率TTM
16.850最高價16.315最低價110.76萬股成交量16.550今開16.400昨收1834.84萬成交額1.09%換手率26.17市盈率(靜)1.18億總股本17.49552周最高3.47市淨率16.80億流通值11.09052周最低--股息TTM1.02億流通股22.110歷史最高--股息率TTM3.26%振幅0.370歷史最低16.565平均價1股每手
關於Catalyst Pharmaceuticals公司
Catalyst Pharmaceuticals Inc是一家生物製藥公司。該公司專注於爲患有罕見、衰弱、慢性神經肌肉疾病和神經系統疾病的人開發創新療法並將其商業化。該公司供應Firdapse，一種專利形式的磷酸阿米吡啶片，用於治療Lambbert-eaton肌無力綜合症患者。
公司介紹
公司代碼CPRX
公司名稱Catalyst Pharmaceuticals
上市日期2006/11/08
發行價格6.00
成立日期2002
CEOMr. Richard J. Daly
所屬市場納斯達克
員工數量167
證券類型海外普通股
年結日12-31
公司地址355 Alhambra Circle,Suite 801
城市Coral Gables
省份佛羅里達州
國家美國
郵編33134
電話1-305-420-3200
董事高管
- 姓名
- 職務
- 年薪
- Richard J. Daly
- Director, President and Chief Executive Officer
- 1407.69萬
- Brian Elsbernd, J.D.
- Chief Compliance Officer and Chief Legal Officer
- --
- Dr. Steven R. Miller,PhD
- Executive Vice President, Chief Operating Officer and Chief Scientific Officer
- 340.47萬
- Jeffrey Del Carmen
- Executive Vice President and Chief Commercial Officer
- 250.61萬
- Michael W. Kalb
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Preethi Sundaram, PhD
- Chief Strategy Officer
- --
- Dr. Gary Ingenito,M.D.,PhD
- Chief Medical and Regulatory Officer
- 237.14萬
- Patrick J. McEnany
- Non-Executive Chairman of the Board
- 214.65萬
- Molly Harper
- Independent Director
- 36.31萬
- Dr. David S. Tierney,M.D.
- Independent Director
- 37.10萬
- Donald A. Denkhaus
- Independent Director
- 37.62萬
- Tamar Thompson
- Independent Director
- 61.04萬
- Charles B. O'Keeffe
- Lead Independent Director
- 39.72萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅